Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Juvenile spondylarthropathy].

C Job-Deslandre1

  • 1Service de Rhumatologie A, Hopital Cochin, Paris.

Presse Medicale (Paris, France : 1983)
|April 4, 2000
PubMed
Summary
This summary is machine-generated.

Juvenile spondylarthropathy, a form of juvenile idiopathic arthritis, affects boys and involves joints and tendons. While often episodic, most patients experience good functional prognosis with appropriate treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A large national cohort of French patients with chronic recurrent multifocal osteitis.

Arthritis & rheumatology (Hoboken, N.J.)·2014
Same author

[Guidelines for diagnosis and treatment of oligoarticular and polyarticular juvenile idiopathic arthritis].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2010
Same author

Clinical outcome in children with chronic recurrent multifocal osteomyelitis.

Rheumatology (Oxford, England)·2008
Same author

Infliximab efficacy and safety against refractory systemic necrotising vasculitides: long-term follow-up of 15 patients.

Annals of the rheumatic diseases·2008
Same author

[Laboratory studies in pediatric bone and joint infections].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2007
Same author

Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France.

Annals of the rheumatic diseases·2007
Same journal

Predictive analytics and risk stratification models in internal medicine: from risk scores to real-time machine learning.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in skin disease therapeutics: from drug discovery to personalized treatment pathways.

Presse medicale (Paris, France : 1983)·2026
Same journal

AI in clinical diagnostics in dermatology: applications, validation, and real-world use cases.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in medical research and publishing: progress, risks, and future perspectives.

Presse medicale (Paris, France : 1983)·2026
Same journal

Ethical, legal, and regulatory challenges in AI-based healthcare tools.

Presse medicale (Paris, France : 1983)·2026
Same journal

Decision-making for clinicians.

Presse medicale (Paris, France : 1983)·2026
See all related articles

Area of Science:

  • Rheumatology
  • Pediatrics
  • Immunogenetics

Context:

  • Juvenile spondylarthropathy comprises 20% of juvenile idiopathic arthritis cases.
  • Characterized by spinal, peripheral joint, and tendon insertion inflammation.
  • Associated with HLA B27 and predominantly affects boys around age 11.

Purpose:

  • To describe the epidemiology, clinical presentation, and treatment of juvenile spondylarthropathy.
  • To outline diagnostic criteria and clinical course.
  • To evaluate the functional prognosis and long-term outcomes.

Summary:

  • Presents with asymmetrical lower limb joint involvement and enthesopathy (30-50%).
  • Diagnosis relies on Amor and ESSG criteria.
  • Typically follows an episodic pattern (80%) with a generally good functional prognosis.

Related Experiment Videos

Impact:

  • Nonsteroidal anti-inflammatory drugs and local care are primary treatments.
  • Sulfasalazine's efficacy is unproven.
  • Good functional prognosis is expected, with spinal ankylosis uncommon and hip involvement (destructive coxitis) in 30% of patients; 80% have minimal disability after 10 years.